Public health interventions for reducing HIV, hepatitis B and hepatitis C infections in people who inject drugs.
作者信息
Richardson D, Bell C
机构信息
Brighton & Sussex University Hospitals National Health Service Trust, Brighton & Sussex Medical School, Brighton, UK.
Adelaide Sexual Health Centre, Adelaide, South Australia, Australia.
出版信息
Public Health Action. 2018 Dec 21;8(4):153. doi: 10.5588/pha.18.0093-ed.
Abstract
摘要
相似文献
1
Public health interventions for reducing HIV, hepatitis B and hepatitis C infections in people who inject drugs.减少注射吸毒者艾滋病毒、乙型肝炎和丙型肝炎感染的公共卫生干预措施。
Public Health Action. 2018 Dec 21;8(4):153. doi: 10.5588/pha.18.0093-ed.
2
3
HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.桑给巴尔注射毒品者中的艾滋病毒与乙型和丙型肝炎合并感染情况。
BMC Public Health. 2017 Nov 28;17(1):917. doi: 10.1186/s12889-017-4933-0.
4
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.注射吸毒的流行病学、与注射相关的危害的流行率，以及注射吸毒者的行为和环境风险的暴露情况：系统评价。
Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27.
5
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.一项在德国采用应答者驱动抽样方法对注射吸毒者进行的乙型和丙型肝炎、艾滋病毒及人类嗜T淋巴细胞病毒的多中心血清行为调查。
BMC Public Health. 2014 Aug 14;14:845. doi: 10.1186/1471-2458-14-845.
6
The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.完美风暴：监禁与东欧和中亚地区助长艾滋病毒、丙型肝炎病毒及结核病传播的高风险环境
Lancet. 2016 Sep 17;388(10050):1228-48. doi: 10.1016/S0140-6736(16)30856-X. Epub 2016 Jul 14.
7
Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study.尼泊尔加德满都谷地注射毒品女性中艾滋病毒、丙型肝炎及其相关风险行为的流行情况：一项横断面研究。
Ther Adv Infect Dis. 2021 Dec 3;8:20499361211062107. doi: 10.1177/20499361211062107. eCollection 2021 Jan-Dec.
8
Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China.模拟预防和治疗干预措施对中国注射吸毒人群丙型肝炎的影响。
Infect Dis Ther. 2023 Apr;12(4):1043-1055. doi: 10.1007/s40121-023-00779-0. Epub 2023 Mar 9.
9
A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?一项全球范围内对注射吸毒者中 HIV、丙型肝炎病毒和乙型肝炎病毒流行率的荟萃分析——按国家层面指标划分，性别差异是否存在？
J Infect Dis. 2019 Jun 5;220(1):78-90. doi: 10.1093/infdis/jiz058.
10
Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.科威特注射吸毒人群中的乙型肝炎病毒、丙型肝炎病毒和人类免疫缺陷病毒感染：一项横断面研究。
Sci Rep. 2019 Apr 18;9(1):6292. doi: 10.1038/s41598-019-42810-w.
引用本文的文献
1
Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA.在美国宾夕法尼亚州费城，识别药物使用人群中乙型肝炎和德尔塔病毒筛查、预防和关联护理的障碍。
Harm Reduct J. 2024 Nov 15;21(1):199. doi: 10.1186/s12954-024-01117-4.
2
Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia.消除费城吸毒者社区中乙肝和丁肝筛查、预防及护理衔接的障碍。
Viruses. 2024 Apr 18;16(4):628. doi: 10.3390/v16040628.
3
Epidemiological study of hepatitis B and hepatitis C infection in Kohgiluyeh and Boyer-Ahmad province (Iran) from 2008 to 2021: A cross-sectional study.2008年至2021年伊朗科吉卢耶-博韦艾哈迈德省乙型和丙型肝炎感染的流行病学研究：一项横断面研究。
Health Sci Rep. 2024 Feb 7;7(2):e1812. doi: 10.1002/hsr2.1812. eCollection 2024 Feb.
4
HIV and its associated factors among people who inject drugs in Mizoram, Northeast India.印度东北部米佐拉姆邦注射吸毒人群中的 HIV 及其相关因素。
PLoS One. 2023 May 22;18(5):e0286009. doi: 10.1371/journal.pone.0286009. eCollection 2023.
5
A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran.伊朗注射吸毒人群丙型肝炎病毒感染率的系统评价和荟萃分析。
BMC Public Health. 2020 Jan 14;20(1):62. doi: 10.1186/s12889-020-8175-1.
本文引用的文献
1
HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar.缅甸仰光接受美沙酮维持治疗的注射吸毒者中的艾滋病毒、乙肝病毒和丙肝病毒
Public Health Action. 2018 Dec 21;8(4):202-210. doi: 10.5588/pha.18.0050.
2
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.全球注射吸毒流行状况以及注射吸毒者的社会人口学特征和艾滋病毒、乙肝病毒及丙肝病毒流行状况：多阶段系统评价。
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
3
Injecting drug use in low and middle-income countries: Opportunities to improve care and prevent harm.低收入和中等收入国家的注射吸毒问题：改善护理和预防伤害的机遇
J Viral Hepat. 2017 Sep;24(9):714-724. doi: 10.1111/jvh.12741. Epub 2017 Aug 1.
4
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.估算因注射吸毒作为 HIV、丙型肝炎和乙型肝炎的风险因素而导致的疾病负担：来自 2013 年全球疾病负担研究的结果。
Lancet Infect Dis. 2016 Dec;16(12):1385-1398. doi: 10.1016/S1473-3099(16)30325-5. Epub 2016 Sep 21.
5
Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection.匈牙利注射吸毒者中的边缘化群体与社会融入群体：艾滋病毒感染的潜在桥梁
J Urban Health. 2005 Sep;82(3 Suppl 4):iv101-12. doi: 10.1093/jurban/jti112.
Zotero 插件